Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Qingre Huayu Recipe (JQH) is a Traditional Chinese Medicine (TCM) herbal formula developed through collaboration between Guangzhou University of Traditional Chinese Medicine, Central South University, and Shenzhen Traditional Chinese Medicine Hospital. Administered orally, JQH is primarily indicated for the treatment of gastric ulcers and precancerous lesions of gastric cancer (PLGC), including chronic atrophic gastritis. The formula's therapeutic mechanism involves the modulation of multiple biological pathways, including the inhibition of Interleukin-8 (IL-8) and the regulation of the JAK-STAT, Wnt, p53, and vascular endothelial growth factor (VEGF) signaling pathways. These actions contribute to improved immune function, reduced inflammation, and the inhibition of the transformation from gastritis to gastric cancer. Network pharmacology has identified quercetin as a key active ingredient within the recipe.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Qingre Huayu Recipe.